N.J. High Court Mulls Vioxx Class Status; $30B At Stake

Law360, New York (July 24, 2006, 12:00 AM EDT) -- In a decision that dramatically raises the stakes for Merck & Co., New Jersey’s State Supreme Court has agreed to hear the drug maker’s appeal of the class certification of a Vioxx lawsuit brought by a union and other third-party payors.

The latest development in Merck’s extensive and drawn-out litigation over the pain killer was first reported Monday by the Wall Street Journal’s online edition.

The lawsuit, which seeks reimbursement of $9.6 billion of Vioxx purchases, was certified by Judge Carol E. Higbee last July, a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.